The COPD 2026 Guideline focuses on earlier detection, personalized treatment, and prevention of exacerbations. It emphasizes routine use of spirometry, expanded screening for high-risk groups, and a stronger shift toward combination inhaler therapy tailored to symptom burden and exacerbation history. The guideline also highlights pulmonary rehabilitation, smoking cessation support, vaccination updates, and the use of digital monitoring tools to track symptoms and reduce hospitalizations.
Join renowned Pulmonary Medicine specialist Dr. S Raghu and an expert panel of pulmonologists for an engaging session on “ COPD New Guideline 2026 .” This insightful discussion is part of a monthly series conducted in collaboration with the Association of Pulmonologists Seema Andhra (APSA) and will take place on 25 th November 2025 from 8:00 PM to 9.30 PM . Don’t miss this opportunity to deepen your…
